Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder

Neuropsychopharmacology, Published online: 29 June 2019; doi:10.1038/s41386-019-0451-3Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder

Source: Neuropsychopharmacology - June 28, 2019 Category: Neurology Authors: Michael E. Thase Arielle D. Stanford Asli Memisoglu William Martin Amy Claxton J. Alexander Bodkin Madhukar H. Trivedi Maurizio Fava Miao Yu Sanjeev Pathak Source Type: research